NCT03468699View on ClinicalTrials.gov

Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

September 30, 2021

Study Completion Date

October 31, 2021

Conditions
Liver Cirrhosis, Biliary
Interventions
COMBINATION_PRODUCT

Autologous BMMC transplantation

Stem cell transplantation

Trial Locations (2)

10000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

100000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT03468699 - Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia | Biotech Hunter | Biotech Hunter